Capricor Therapeutics, Inc.
CAPR· Nasdaq
CAPRCapricor Therapeutics, Inc.
Filed Jun 21, 2013 · 10-Q · 82 days after period end · 0001144204-13-036078
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $233.29K | $195.50K | — |
| Net Income | -$1.42M | -$771.88K | -$1.20M |
| EPS Diluted | -$0.14 | -$0.02 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Capricor Therapeutics, Inc. · CIK 1133869 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed Jun 21, 2013 · 82 d after period end
